These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 23322330)
21. Smart drug delivery through DNA/magnetic nanoparticle gates. Ruiz-Hernández E; Baeza A; Vallet-Regí M ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653 [TBL] [Abstract][Full Text] [Related]
22. General route to multifunctional uniform yolk/mesoporous silica shell nanocapsules: a platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Zhang L; Wang T; Yang L; Liu C; Wang C; Liu H; Wang YA; Su Z Chemistry; 2012 Sep; 18(39):12512-21. PubMed ID: 22907903 [TBL] [Abstract][Full Text] [Related]
23. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. He Q; Shi J; Chen F; Zhu M; Zhang L Biomaterials; 2010 Apr; 31(12):3335-46. PubMed ID: 20106517 [TBL] [Abstract][Full Text] [Related]
24. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Luo Z; Cai K; Hu Y; Zhang B; Xu D Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747 [TBL] [Abstract][Full Text] [Related]
26. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402 [TBL] [Abstract][Full Text] [Related]
27. Defect-related luminescent mesoporous silica nanoparticles employed for novel detectable nanocarrier. Ge K; Zhang C; Jia G; Ren H; Wang J; Tan A; Liang XJ; Zang A; Zhang J ACS Appl Mater Interfaces; 2015 May; 7(20):10905-14. PubMed ID: 25943277 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of monodisperse hollow carbon nanocapsules by using protective silica shells. Quan B; Nam GE; Choi HJ; Piao Y Chem Asian J; 2013 Apr; 8(4):765-70. PubMed ID: 23345002 [TBL] [Abstract][Full Text] [Related]
29. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles. Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723 [TBL] [Abstract][Full Text] [Related]
30. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667 [TBL] [Abstract][Full Text] [Related]
31. Camptothecin-loaded mesoporous silica nanoparticles functionalized with CpG oligodeoxynucleotide as a new approach for skin cancer treatment. Qureshi M; Viegas C; Duarte SOD; Girardi M; Shehzad A; Fonte P Int J Pharm; 2024 Jul; 660():124340. PubMed ID: 38878838 [TBL] [Abstract][Full Text] [Related]
32. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Chiang YT; Yen YW; Lo CL Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788 [TBL] [Abstract][Full Text] [Related]
33. Highly monodisperse rattle-structured nanomaterials with gold nanorod core-mesoporous silica shell as drug delivery vehicles and nanoreactors. Choi E; Kwak M; Jang B; Piao Y Nanoscale; 2013 Jan; 5(1):151-4. PubMed ID: 23154837 [TBL] [Abstract][Full Text] [Related]
34. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578 [TBL] [Abstract][Full Text] [Related]
35. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics. Liu Y; Miyoshi H; Nakamura M Colloids Surf B Biointerfaces; 2007 Aug; 58(2):180-7. PubMed ID: 17420116 [TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer. Natesan S; Sugumaran A; Ponnusamy C; Jeevanesan V; Girija G; Palanichamy R J Drug Target; 2014 Dec; 22(10):913-26. PubMed ID: 25119147 [TBL] [Abstract][Full Text] [Related]
37. General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics. Ujjwal RR; Purohit MP; Patnaik S; Ojha U ACS Appl Mater Interfaces; 2015 Jun; 7(21):11497-507. PubMed ID: 25961335 [TBL] [Abstract][Full Text] [Related]
40. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]